Search This Blog

Friday, July 19, 2019

Premarket analyst actions: Blueprint, Millendo, HealthEquity

Blueprint Medicines (NASDAQ:BPMC) initiated with Outperform rating and $120 (22% upside) price target at Baird.
Millendo Therapeutics (NASDAQ:MLND) initiated with Outperform rating and $24 (125% upside) price target at Wedbush.
HealthEquity (NASDAQ:HQY) upgraded to Buy at BofA/Merrill Lynch. Shares up 1% premarket.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)